WEDNESDAY, June 30, 2021 (HealthDay News) — Some people suffering from symptoms of COVID long-distance may actually be experiencing an attack of the fatigue-causing Epstein-Barr virus (EBV), argues a new study.
Two-thirds of the group of 30 COVID long-haul patients had high levels of Epstein-Barr antibodies, suggesting that EBV lying dormant in their bodies was reactivated by them coronavirus infection, the researchers reported.
“while SARS-CoV-2 apparently causes acute COVID-19 disease, its inflammatory consequences may lead to the involvement of other agents, particularly EBV, in the complex pathogenesis of disease-associated problems in the long term,” said lead researcher Jeffrey Said Gould, president of the World Organization, an environmental non-profit group.
More than 95% of adults carry Epstein-Barr, a herpesvirus, the researchers said in background notes. Viruses are the most common cause mononucleosis, a disease that constantly exhausts even its victims.
“It’s just there,” said Dr. Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security in Baltimore. It keeps lurking in itself, and anything that stresses your body can cause it. ” “If you look at EBV viral loads in ICU patients, they will increase. Anyone in any kind of stressful situation, there is a possibility that [Epstein-Barr] Will be activated again or it will be copied.”
However, Adalja said more evidence is needed to prove the connection, noting that EBV is widespread among humans and can be triggered by physical or psychological Tension.
For this study, Gould and his colleagues surveyed 185 COVID patients and found that about 30% were suffering from long-distance symptoms.
Taking a closer look at 30 of the long-standing COVID patients, the researchers found that 20 of them had EBV antibody levels high enough to suggest Epstein-Barr reactivation.
These long haul patients with high EBV antibody levels reported fatigue, insomnia, HeadacheTheir most common symptoms are body aches and confusion. Other symptoms include tinnitus (ringing in the ears), Deafness and skin rashes.
The researchers argued that COVID infection is triggering EBV in some patients, and that is what triggers their long-lasting symptoms.